OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 15

Showing 15 citing articles:

Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
Yan Zhuo, Zhengbo Zhang, Yanan Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11

Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8

The danger theory of immunity revisited
Guido Kroemer, Léa Montégut, Oliver Kepp, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 912-928
Closed Access | Times Cited: 4

Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of Pancreatic Cancer
Alina S. Nazarenko, Yulia K. Biryukova, Kirill N. Trachuk, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 40-40
Open Access

Oncolytic Virus Therapy in a New Era of Immunotherapy, Enhanced by Combination with Existing Anticancer Therapies: Turn up the Heat!
Emily Charlotte Fretwell, Annwyne Houldsworth
Journal of Cancer (2025) Vol. 16, Iss. 6, pp. 1782-1793
Open Access

Cancer-Fighting Bioactive Agents Derived from Microbes
Kaushika Olymon, Eshan Abbas, Shivanshi Madeshiya, et al.
(2025), pp. 177-188
Closed Access

Expression of SIRPα-Fc by oncolytic virus enhances antitumor efficacy through tumor microenvironment reprogramming
Qingzhe Yang, Yongheng Shu, Yanwei Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer
Wenyi Yan, Yujing Xuan, Rui Wang, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 882-882
Open Access

The evolving landscape of oncolytic virus immunotherapy: combinatorial strategies and novel engineering approaches
Mujibullah Sheikh, Arshiya Saiyyad, Aimé Aliunui, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access

Viral-Porphyrin Combo: Photodynamic and Oncolytic Viral Therapy for Potent Glioblastoma Treatment
Alina S. Nazarenko, Alena O. Shkirdova, Ekaterina A. Orlova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12578-12578
Open Access

IMPORTANCIA DE LA EDUCACION CONTINUA EN LA PRACTICA DE LA ENFERMERA
Yanetzi Loimig Arteaga Yánez, Neris Marina Ortega-Guevara, Cesar Patricio Jumbo Diaz, et al.
(2024), pp. 30-54
Open Access

Antibiotic-driven boosting of oncolytic virotherapy
Himanshu Soni, E. Antonio Chiocca, Joshua D. Bernstock
Nature Biomedical Engineering (2024)
Closed Access

Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell Sequencing
Saleh Alrhmoun, M.S. Fisher, Julia Lopatnikova, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4020-4020
Open Access

AI-based classification of anticancer drugs reveals nucleolar condensation as a predictor of immunogenicity
Giulia Cerrato, Peng Liu, Liwei Zhao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access

Page 1

Scroll to top